Adaptive Biotechnologies

$41.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.53 (+3.78%) As of 6:02 PM UTC today

Why Robinhood?

You can buy or sell ADPT and other stocks, options, and ETFs commission-free!

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

CEO

Chad Robins

Employees

622

Headquarters

Seattle, Washington

Founded

2009

Market Cap

6.06B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.04M

High Today

$41.90

Low Today

$39.38

Open Price

$39.91

Volume

301.36K

52 Week High

$71.25

52 Week Low

$28.00

Analyst Ratings

75%

of 8 ratings

Buy

75%

Hold

25%

Sell

ADPT Earnings

-$0.33

-$0.22

-$0.11

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Available May 5, After Hours